Scientists have discovered that using a combination of two drugs for treating pancreatic cancer greatly increases patients’ chances of survival for a longer time. Clinical trials have found that 29% of patients who were given two chemotherapy drugs, gemcitabine and capecitabine, lived for at least five years after diagnosis, compared with 16% who received only one of the drugs.

read more at The Guardian

Here's To Your Health
We're reporting in on the latest in health news, medical research, insurance coverage, plus managing your health and the health of the people you love.
We respect your privacy